LAG3 and neoplasm: Notably, CD8+TIM3+ and CD8+LAG3+ cells were predominantly located in the tumor parenchyma of patients with recurrence/metastasis, whereas these cells were mainly distributed in the stromal regions of non-recurrent/non-metastatic patients.